{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T16:16:09Z","timestamp":1761581769226,"version":"3.37.3"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,7]],"date-time":"2018-11-07T00:00:00Z","timestamp":1541548800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","award":["201708210229"],"award-info":[{"award-number":["201708210229"]}],"id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]},{"name":"New Teacher Grant of China Medical University","award":["XZR20160003"],"award-info":[{"award-number":["XZR20160003"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12885-018-4994-1","type":"journal-article","created":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T17:17:10Z","timestamp":1542734230000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["MiR-155, a potential serum marker of extramammary Paget\u2019s disease"],"prefix":"10.1186","volume":"18","author":[{"given":"Hao","family":"Guo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui-Qun","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"He-Xiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiu-Hong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xing-Hua","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yin-Sheng","family":"Wan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Duo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,11,7]]},"reference":[{"key":"4994_CR1","first-page":"448","volume":"9","author":"G Wagner","year":"2011","unstructured":"Wagner G, Sachse MM. Extramammary Paget disease - clinical appearance, pathogenesis, management. J Dtsch Dermatol Ges. 2011;9:448\u201354.","journal-title":"J Dtsch Dermatol Ges"},{"key":"4994_CR2","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.det.2010.08.002","volume":"28","author":"C Lam","year":"2010","unstructured":"Lam C, Funaro D. Extramammary Paget's disease: summary of current knowledge. Dermatol Clin. 2010;28:807\u201326.","journal-title":"Dermatol Clin"},{"key":"4994_CR3","doi-asserted-by":"publisher","first-page":"6804","DOI":"10.4081\/rt.2016.6804","volume":"8","author":"L Padrnos","year":"2016","unstructured":"Padrnos L, Karlin N, Halfdanarson TR. Mayo Clinic Cancer center experience of metastatic Extramammary Paget disease 1998-2012. Rare Tumors. 2016;8:6804.","journal-title":"Rare Tumors"},{"key":"4994_CR4","first-page":"313","volume":"158","author":"N Hatta","year":"2008","unstructured":"Hatta N, Yamada M, Hirano T, Fujimoto A, Morita R. Extramammary Paget's disease: treatment, prognostic factors and outcome in 76 patients. Br J Dermatol. 2008;158:313\u20138.","journal-title":"Br J Dermatol"},{"key":"4994_CR5","doi-asserted-by":"publisher","first-page":"850","DOI":"10.4161\/rna.20378","volume":"9","author":"M Weiland","year":"2012","unstructured":"Weiland M, Gao XH, Zhou L, Mi QS. Small RNAs have a large impact: circulating microRNAs as biomarkers for human diseases. RNA Biol. 2012;9:850\u20139.","journal-title":"RNA Biol"},{"key":"4994_CR6","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1001\/jama.2013.284664","volume":"311","author":"NA Schultz","year":"2014","unstructured":"Schultz NA, Dehlendorff C, Jensen BV, Bjerregaard JK, Nielsen KR, Bojesen SE, Calatayud D, Nielsen SE, Yilmaz M, Hollander NH, et al. MicroRNA biomarkers in whole blood for detection of pancreatic cancer. JAMA. 2014;311:392\u2013404.","journal-title":"JAMA"},{"key":"4994_CR7","doi-asserted-by":"crossref","unstructured":"Swellam M, Zahran RFK, Abo El-Sadat Taha H, El-Khazragy N, Abdel-Malak C. Role of some circulating MiRNAs on breast cancer diagnosis. Arch Physiol Biochem. 2018.\u00a0[Epub ahead of print].","DOI":"10.1080\/13813455.2018.1482355"},{"key":"4994_CR8","doi-asserted-by":"crossref","first-page":"24559","DOI":"10.18632\/oncotarget.8230","volume":"7","author":"H Guo","year":"2016","unstructured":"Guo H, Qi RQ, Lv YN, Wang HX, Hong YX, Zheng S, Li JH, Gao XH, Chen HD. miR-31 is distinctively overexpressed in primary male extramammary Paget's disease. Oncotarget. 2016;7:24559\u201363.","journal-title":"Oncotarget"},{"key":"4994_CR9","first-page":"3768247","volume":"2017","author":"S Zhou","year":"2017","unstructured":"Zhou S, Zhong W, Mai R, Zhang G. Mammary and Extramammary Paget's disease presented different expression pattern of steroid hormone receptors. Biomed Res Int. 2017;2017:3768247.","journal-title":"Biomed Res Int"},{"key":"4994_CR10","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.amsu.2016.06.012","volume":"9","author":"G Carbotta","year":"2016","unstructured":"Carbotta G, Sallustio P, Prestera A, Laforgia R, Lobascio P, Palasciano N. Perineal Paget's disease: a rare disorder and review of literature. Ann Med Surg (Lond). 2016;9:50\u20132.","journal-title":"Ann Med Surg (Lond)"},{"key":"4994_CR11","first-page":"168","volume":"15","author":"Y Murata","year":"2005","unstructured":"Murata Y, Kumano K. Extramammary Paget's disease of the genitalia with clinically clear margins can be adequately resected with 1 cm margin. Eur J Dermatol. 2005;15:168\u201370.","journal-title":"Eur J Dermatol"},{"key":"4994_CR12","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1001\/archderm.1979.04010060014018","volume":"115","author":"FE Mohs","year":"1979","unstructured":"Mohs FE, Blanchard L. Microscopically controlled surgery for extramammary Paget's disease. Arch Dermatol. 1979;115:706\u20138.","journal-title":"Arch Dermatol"},{"key":"4994_CR13","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1046\/j.1524-4725.2003.29184.x","volume":"29","author":"WJ O'Connor","year":"2003","unstructured":"O'Connor WJ, Lim KK, Zalla MJ, Gagnot M, Otley CC, Nguyen TH, Roenigk RK. Comparison of mohs micrographic surgery and wide excision for extramammary Paget's disease. Dermatol Surg. 2003;29:723\u20137.","journal-title":"Dermatol Surg"},{"key":"4994_CR14","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1097\/PAS.0000000000000709","volume":"40","author":"Z Kang","year":"2016","unstructured":"Kang Z, Xu F, Zhu Y, Fu P, Zhang QA, Hu T, Li X, Zhang Q, Wu Z, Zhang X, et al. Genetic analysis of mismatch repair genes alterations in Extramammary Paget disease. Am J Surg Pathol. 2016;40:1517\u201325.","journal-title":"Am J Surg Pathol"},{"key":"4994_CR15","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1111\/1346-8138.13760","volume":"44","author":"J Kato","year":"2017","unstructured":"Kato J, Sumikawa Y, Hida T, Kamiya T, Horimoto K, Kamiya S, Sato S, Takahashi H, Sawada M, Yamashita T. Serum cytokeratin 19 fragment 21-1 is a useful tumor marker for the assessment of extramammary Paget's disease. J Dermatol. 2017;44:666\u201370.","journal-title":"J Dermatol"},{"key":"4994_CR16","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/j.1365-2133.1984.tb07469.x","volume":"110","author":"M Oji","year":"1984","unstructured":"Oji M, Furue M, Tamaki K. Serum carcinoembryonic antigen level in Paget's disease. Br J Dermatol. 1984;110:211\u20133.","journal-title":"Br J Dermatol"},{"key":"4994_CR17","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/jcp.25056","volume":"231","author":"J Wang","year":"2016","unstructured":"Wang J, Chen J, Sen S. MicroRNA as biomarkers and diagnostics. J Cell Physiol. 2016;231:25\u201330.","journal-title":"J Cell Physiol"},{"key":"4994_CR18","doi-asserted-by":"publisher","first-page":"e115448","DOI":"10.1371\/journal.pone.0115448","volume":"9","author":"Y Lv","year":"2014","unstructured":"Lv Y, Qi R, Xu J, Di Z, Zheng H, Huo W, Zhang L, Chen H, Gao X. Profiling of serum and urinary microRNAs in children with atopic dermatitis. PLoS One. 2014;9:e115448.","journal-title":"PLoS One"},{"key":"4994_CR19","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1111\/j.1468-3083.2007.02438.x","volume":"21","author":"J Kanitakis","year":"2007","unstructured":"Kanitakis J. Mammary and extramammary Paget's disease. J Eur Acad Dermatol Venereol. 2007;21:581\u201390.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4994_CR20","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/S0190-9622(85)70254-X","volume":"13","author":"JJ Chanda","year":"1985","unstructured":"Chanda JJ. Extramammary Paget's disease: prognosis and relationship to internal malignancy. J Am Acad Dermatol. 1985;13:1009\u201314.","journal-title":"J Am Acad Dermatol"},{"key":"4994_CR21","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1001\/archderm.1985.01660060064022","volume":"121","author":"Y Merot","year":"1985","unstructured":"Merot Y, Mazoujian G, Pinkus G, Momtaz TK, Murphy GF. Extramammary Paget's disease of the perianal and perineal regions. Evidence of apocrine derivation. Arch Dermatol. 1985;121:750\u20132.","journal-title":"Arch Dermatol"},{"key":"4994_CR22","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1038\/labinvest.3780153","volume":"80","author":"A Fujimoto","year":"2000","unstructured":"Fujimoto A, Takata M, Hatta N, Takehara K. Expression of structurally unaltered androgen receptor in extramammary Paget's disease. Lab Investig. 2000;80:1465\u201371.","journal-title":"Lab Investig"},{"key":"4994_CR23","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/00000478-198401000-00004","volume":"8","author":"G Mazoujian","year":"1984","unstructured":"Mazoujian G, Pinkus GS, Haagensen DE Jr. Extramammary Paget's disease--evidence for an apocrine origin. An immunoperoxidase study of gross cystic disease fluid protein-15, carcinoembryonic antigen, and keratin proteins. Am J Surg Pathol. 1984;8:43\u201350.","journal-title":"Am J Surg Pathol"},{"key":"4994_CR24","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1046\/j.1524-4741.2003.09610.x","volume":"9","author":"W Hanna","year":"2003","unstructured":"Hanna W, Alowami S, Malik A. The role of HER-2\/neu oncogene and vimentin filaments in the production of the Paget's phenotype. Breast J. 2003;9:485\u201390.","journal-title":"Breast J"},{"key":"4994_CR25","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1111\/j.1440-1827.2010.02591.x","volume":"60","author":"O Giger","year":"2010","unstructured":"Giger O, Caduff R, O'Meara A, Diener PA, Knuth A, Jager D, Moch H, Varga Z. Frequent expression of the breast differentiation antigen NY-BR-1 in mammary and extramammary Paget's disease. Pathol Int. 2010;60:726\u201334.","journal-title":"Pathol Int"},{"key":"4994_CR26","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/bjc.1988.222","volume":"58","author":"A Imam","year":"1988","unstructured":"Imam A, Yoshida SO, Taylor CR. Distinguishing tumour cells of mammary from extramammary Paget's disease using antibodies to two different glycoproteins from human milk-fat-globule membrane. Br J Cancer. 1988;58:373\u20138.","journal-title":"Br J Cancer"},{"key":"4994_CR27","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/j.1365-2133.1985.tb02039.x","volume":"113","author":"K Tamaki","year":"1985","unstructured":"Tamaki K, Hino H, Ohara K, Furue M. Lectin-binding sites in Paget's disease. Br J Dermatol. 1985;113:17\u201324.","journal-title":"Br J Dermatol"},{"key":"4994_CR28","doi-asserted-by":"crossref","unstructured":"Schwarz LJ, Hutchinson KE, Rexer BN, Estrada MV, Gonzalez Ericsson PI, Sanders ME, Dugger TC, Formisano L, Guerrero-Zotano A, Red-Brewer M, et al. An ERBB1-3 neutralizing antibody mixture with high activity against drug-resistant HER2+ breast cancers with ERBB ligand overexpression. J Natl Cancer Inst. 2017;109:1\u201310.","DOI":"10.1093\/jnci\/djx065"},{"issue":"4","key":"4994_CR29","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1093\/jnci\/djx207","volume":"110","author":"Hee-Joo Choi","year":"2017","unstructured":"Choi HJ, Joo HS, Won HY, Min KW, Kim HY, Son T, Oh YH, Lee JY, Kong G. Role of RBP2-induced ER and IGF1R-ErbB signaling in tamoxifen resistance in breast Cancer. J Natl Cancer Inst. 2018;110:1\u201311.","journal-title":"JNCI: Journal of the National Cancer Institute"},{"key":"4994_CR30","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.anndiagpath.2017.05.006","volume":"30","author":"Y Hou","year":"2017","unstructured":"Hou Y, Shen R, Chaudhary S, Tonkovich D, Li Z. Utility of different immunostains for diagnosis of metastatic breast carcinomas in both surgical and cytological specimens. Ann Diagn Pathol. 2017;30:21\u20137.","journal-title":"Ann Diagn Pathol"},{"key":"4994_CR31","doi-asserted-by":"crossref","first-page":"84996","DOI":"10.18632\/oncotarget.18662","volume":"8","author":"H Wu","year":"2017","unstructured":"Wu H, Wang H, Guan S, Zhang J, Chen Q, Wang X, Ma K, Zhao P, Zhao H, Yao W, et al. Cell-specific regulation of proliferation by Ano1\/TMEM16A in breast cancer with different ER, PR, and HER2 status. Oncotarget. 2017;8:84996\u20135013.","journal-title":"Oncotarget"},{"key":"4994_CR32","first-page":"13233","volume":"8","author":"Z Kang","year":"2015","unstructured":"Kang Z, Zhang Q, Zhang Q, Li X, Hu T, Xu X, Wu Z, Zhang X, Wang H, Xu J, et al. Clinical and pathological characteristics of extramammary Paget's disease: report of 246 Chinese male patients. Int J Clin Exp Pathol. 2015;8:13233\u201340.","journal-title":"Int J Clin Exp Pathol"},{"key":"4994_CR33","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1111\/j.1349-7006.2004.tb03238.x","volume":"95","author":"W Tian","year":"2004","unstructured":"Tian W, Osawa M, Horiuchi H, Tomita Y. Expression of the prolactin-inducible protein (PIP\/GCDFP15) gene in benign epithelium and adenocarcinoma of the prostate. Cancer Sci. 2004;95:491\u20135.","journal-title":"Cancer Sci"},{"key":"4994_CR34","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1111\/apm.12504","volume":"124","author":"AH Seipel","year":"2016","unstructured":"Seipel AH, Samaratunga H, Delahunt B, Wiklund P, Clements M, Egevad L. Immunohistochemistry of ductal adenocarcinoma of the prostate and adenocarcinomas of non-prostatic origin: a comparative study. APMIS. 2016;124:263\u201370.","journal-title":"APMIS"},{"key":"4994_CR35","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1158\/0008-5472.CAN-16-1656","volume":"77","author":"KC Day","year":"2017","unstructured":"Day KC, Lorenzatti Hiles G, Kozminsky M, Dawsey SJ, Paul A, Broses LJ, Shah R, Kunja LP, Hall C, Palanisamy N, et al. HER2 and EGFR overexpression support metastatic progression of prostate Cancer to bone. Cancer Res. 2017;77:74\u201385.","journal-title":"Cancer Res"},{"key":"4994_CR36","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1007\/s00268-012-1814-7","volume":"37","author":"Y Peng","year":"2013","unstructured":"Peng Y, Wang L, Gu J. Elevated preoperative carcinoembryonic antigen (CEA) and Ki67 is predictor of decreased survival in IIA stage colon cancer. World J Surg. 2013;37:208\u201313.","journal-title":"World J Surg"},{"key":"4994_CR37","doi-asserted-by":"publisher","first-page":"262","DOI":"10.3816\/CCC.2004.n.025","volume":"4","author":"AM Ochs","year":"2004","unstructured":"Ochs AM, Wong L, Kakani V, Neerukonda S, Gorske J, Rao A, Riggs M, Ward H, Keville L. Expression of vascular endothelial growth factor and HER2\/neu in stage II colon cancer and correlation with survival. Clin Colorectal Cancer. 2004;4:262\u20137.","journal-title":"Clin Colorectal Cancer"},{"key":"4994_CR38","doi-asserted-by":"crossref","unstructured":"Basova P, Pesta M, Sochor M, Stopka T. Prediction potential of serum miR-155 and miR-24 for relapsing early breast Cancer. Int J Mol Sci. 2017;18:E2116.","DOI":"10.3390\/ijms18102116"},{"key":"4994_CR39","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.ygyno.2010.07.021","volume":"119","author":"F Wang","year":"2010","unstructured":"Wang F, Zheng Z, Guo J, Ding X. Correlation and quantitation of microRNA aberrant expression in tissues and sera from patients with breast tumor. Gynecol Oncol. 2010;119:586\u201393.","journal-title":"Gynecol Oncol"},{"key":"4994_CR40","doi-asserted-by":"publisher","first-page":"4536","DOI":"10.1073\/pnas.1402604111","volume":"111","author":"P Gasparini","year":"2014","unstructured":"Gasparini P, Lovat F, Fassan M, Casadei L, Cascione L, Jacob NK, Carasi S, Palmieri D, Costinean S, Shapiro CL, et al. Protective role of miR-155 in breast cancer through RAD51 targeting impairs homologous recombination after irradiation. Proc Natl Acad Sci U S A. 2014;111:4536\u201341.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4994_CR41","doi-asserted-by":"publisher","first-page":"533","DOI":"10.3892\/mmr.2014.2744","volume":"11","author":"ZK Cai","year":"2015","unstructured":"Cai ZK, Chen Q, Chen YB, Gu M, Zheng DC, Zhou J, Wang Z. microRNA-155 promotes the proliferation of prostate cancer cells by targeting annexin 7. Mol Med Rep. 2015;11:533\u20138.","journal-title":"Mol Med Rep"},{"key":"4994_CR42","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.intimp.2014.12.040","volume":"24","author":"H Yang","year":"2015","unstructured":"Yang H, Liu C, Zhang YQ, Ge LT, Chen J, Jia XQ, Gu RX, Sun Y, Sun WD. Ilexgenin a induces B16-F10 melanoma cell G1\/S arrest in vitro and reduces tumor growth in vivo. Int Immunopharmacol. 2015;24:423\u201331.","journal-title":"Int Immunopharmacol"},{"key":"4994_CR43","doi-asserted-by":"publisher","first-page":"604","DOI":"10.4103\/0973-1482.175432","volume":"14","author":"H Cao","year":"2018","unstructured":"Cao H, Huang S, Liu A, Chen Z. Up-regulated expression of miR-155 in human colonic cancer. J Cancer Res Ther. 2018;14:604\u20137.","journal-title":"J Cancer Res Ther"},{"key":"4994_CR44","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s12885-017-3158-z","volume":"17","author":"F Forzati","year":"2017","unstructured":"Forzati F, De Martino M, Esposito F, Sepe R, Pellecchia S, Malapelle U, Pellino G, Arra C, Fusco A. miR-155 is positively regulated by CBX7 in mouse embryonic fibroblasts and colon carcinomas, and targets the KRAS oncogene. BMC Cancer. 2017;17:170.","journal-title":"BMC Cancer"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-4994-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-018-4994-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-4994-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,15]],"date-time":"2020-11-15T16:55:32Z","timestamp":1605459332000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-018-4994-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,7]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["4994"],"URL":"https:\/\/doi.org\/10.1186\/s12885-018-4994-1","relation":{},"ISSN":["1471-2407"],"issn-type":[{"type":"electronic","value":"1471-2407"}],"subject":[],"published":{"date-parts":[[2018,11,7]]},"assertion":[{"value":"26 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This work was reviewed and approved by Ethics Committees of No.1 Hospital of China Medical University (No. AF-SOP-07-1.0-01). All patients gave written informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"1078"}}